Article
Deep spatial-omics to aid personalization of precision medicine in metastatic recurrent Head & Neck Cancers
2023-02-13
Abstract excerpt
Immune checkpoint inhibitor (ICI) modality has had a limited success (<20%) in treating metastatic recurrent Head & Neck Oropharyngeal Squamous cell carcinomas (OPSCCs). To improve response rates to ICIs, tailored approaches capable to capture the tumor complexity and dynamics of each patient’s disease are needed. Here, we performed advanced analyses of spatial proteogenomic technologies to demonstrate that: (i) c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5bfbe41-a965-51f7-84b3-77c45cf06dc5
- DOI
- 10.1101/2023.02.10.527955
